Search Results for "CAR-T therapy for high-risk MCL patients"

CAR-T therapy for high-risk MCL patients

Prognostic markers in MCL and the value of CAR-T therapy in treating high-risk disease

An overview of CAR-T therapy in DLBCL and MCL

Finding the Right Therapy for High-Risk Mantle Cell Lymphoma

Managing the toxicities and increased infection risk for patients receiving CAR-T

Dr. Frey on CAR T-Cell Therapy in High-Risk ALL

The potential of CAR-T therapy in MCL

Rationale for CAR-T to Treat R/R MCL

CAR T-Cell Therapy in High-Risk Non-Hodgkin Lymphoma

Outcomes of autoSCT, alloSCT & CAR-T cell therapy in patients with TP53-altered MCL

Which patients with R/R MCL benefit from CAR-T therapy?

Dr. Leslie on the Development of CAR T-Cell Therapy in DLBCL and MCL